Luteolin protects the hippocampus against neuron impairments induced by kainic acid in rats

NeuroToxicology

Volumn 55, Issue , 2016, Pages 48-57

  Lin, Tzu Yu ^a,c   Lu, Cheng Wei ^a,c   Wang, Su Jane ^b  

^a FAR EASTERN MEMORIAL HOSPITAL   (Taiwan)

^b FU JEN CATHOLIC UNIVERSITY   (Taiwan)

^c YUAN ZE UNIVERSITY   (Taiwan)

Author keywords

Cognitive function; Excitotoxicity; Hippocampus; Kainic acid; Luteolin; Neuroprotection

Indexed keywords

GLUTAMIC ACID; LUTEOLIN; PROTEIN KINASE B; AMINO ACID RECEPTOR STIMULATING AGENT; CD11B ANTIGEN; FLUORESCEIN DERIVATIVE; FLUORO JADE; KAINIC ACID; NEUROPROTECTIVE AGENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN DAMAGE; CELL ACTIVATION; CONTROLLED STUDY; DRUG MECHANISM; ENZYME ACTIVATION; ENZYME PHOSPHORYLATION; HIPPOCAMPUS; HISTOPATHOLOGY; LEARNING DISORDER; MALE; MEMORY DISORDER; MICROGLIA; MORRIS WATER MAZE TEST; NERVE CELL NECROSIS; NEUROPROTECTION; NONHUMAN; PRIORITY JOURNAL; RAT; SEIZURE; WESTERN BLOTTING; ANIMAL; CELL DEATH; CHEMICALLY INDUCED; DISEASE MODEL; DOSE RESPONSE; DRUG EFFECTS; ENDOPLASMIC RETICULUM; MAZE TEST; METABOLISM; MITOCHONDRION; NERVE CELL; PATHOLOGY; SIGNAL TRANSDUCTION; SPRAGUE DAWLEY RAT; TRANSMISSION ELECTRON MICROSCOPY; ULTRASTRUCTURE;

ANIMALS; CD11B ANTIGEN; CELL DEATH; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; ENDOPLASMIC RETICULUM; EXCITATORY AMINO ACID AGONISTS; FLUORESCEINS; GLUTAMIC ACID; HIPPOCAMPUS; KAINIC ACID; LUTEOLIN; MALE; MAZE LEARNING; MICROSCOPY, ELECTRON, TRANSMISSION; MITOCHONDRIA; NEURONS; NEUROPROTECTIVE AGENTS; RATS; RATS, SPRAGUE-DAWLEY; SEIZURES; SIGNAL TRANSDUCTION;

EID: 84969975052     PISSN: 0161813X     EISSN: 18729711     Source Type: Journal    
DOI: 10.1016/j.neuro.2016.05.008     Document Type: Article

References (53)

1. Bahn S., Volk B., Widsen W. Kainate receptor gene eexpression in the developing rat brain. J. Neurosci. 1994, 14:5525-5547.
2. Bhowmik M., Khanam R., Saini N., Vohora D. Activation of AKT/GSK3β pathway by TDZD-8 attenuates kainic acid induced neurodegeneration but not seizures in mice. Neurotoxicology 2015, 46:44-52.
3. Chang C.Y., Lin T.Y., Lu C.W., Huang S.K., Wang Y.C., Chou S.S.P., Wang S.J. Hesperidin inhibits glutamate release and exerts neuroprotection against excitotoxicity induced by kainic acid in the hippocampus of rats. Neurotoxicology 2015, 50:157-169.
4. Chittajallu R., Vignes M., Dev K.K., Barnes J.M., Collingridge G.L., Henley J.M. Regulation of glutamate release by presynaptic kainate receptors in the hippocampus. Nature 1996, 379:78-91.
5. Coleta M., Campos M.G., Cotrim M.D., de Lima T.C.M., da Cunha A.P. Assessment of luteolin (3,4,5,7-tetrahydroxyflavone) neuropharmacological activity. Behav. Brain Res. 2008, 189:75-82.
6. Daglia M., Di Lorenzo A., Nabavi S.F., Talas Z.S., Nabavi S.M. Polyphenols: well beyond the antioxidant capacity: gallic acid and related compounds as neuroprotective agents: you are what you eat!. Curr. Pharm. Biotechnol. 2014, 15:362-372.
7. Ferkany J.W., Coyle J.T. Kainic acid selectively stimulates the release of endogenous excitatory acid amino acid. J. Pharmacol. Exp. Ther. 1983, 225:399-406.
8. A receptor gene expression in adult rat hippocampus: an in situ hybridization study. J. Neurosci. 1994, 14:1697-1707.
9. Fu X., Zhang J., Guo L., Xu Y., Sun L., Wang S., Feng Y., Gou L., Zhang L., Liu Y. Protective role of luteolin against cognitive dysfunction induced by chronic cerebral hypoperfusion in rats. Pharmacol. Biochem. Behav. 2014, 126:122-130.
10. Golechha M., Chaudhry U., Bhatia J., Saluja D., Arya D.S. Naringin protects against kainic acid-induced status epilepticus in rats: evidence for an antioxidant, anti-inflammatory and neuroprotective intervention. Biol. Pharm. Bull. 2011, 34:360-365.
11. Han J.H., Ahn S.Y., Kim C.S., Yoo S.K., Kim S.K., Kim H.C., Hong J.T., Oh K.W. Protection of apigenin against kainate-induced excitotoxicity by anti-oxidative effects. Biol. Pharm. Bull. 2012, 35:1440-1446.
12. Havsteen B.H. The biochemistry and medical significance of the flavonoids. Pharmacol. Ther. 2002, 96:67-202.
13. Ishisaka M., Kakefuda K., Yamauchi M., Tsuruma K., Shimazawa M., Tsuruta A., Hara H. Luteolin shows an antidepressant-like effect via suppressing endoplasmic reticulum stress. Biol. Pharm. Bull. 2011, 34:1481-1486.
14. Jang S., Dilger R.N., Johnson R.W. Luteolin inhibits microglia and alters hippocampal-dependent spatial working memory in aged mice. J. Nutr. 2010, 140:1892-1898.
15. Jorgensen M.B., Finsen B.R., Jensen M.B., Castellano B., Diemer N.H., Zimmer J. Microglial and astroglial reactions to ischemic and kainic acid-induced lesions of the adult rat hippocampus. Exp. Neurol. 1993, 120:70-88.
16. Kammerer M., Brawek B., Freiman T.M., Jackisch R., Feuerstein J. Effects of antiepileptic drugs on glutamate release from rat and human neocortical synaptosomes. Naunyn-Schmied Arch. Pharmacol. 2011, 383:531-542.
17. Kim D.H., Yoon B.H., Jung W.Y., Kim J.M., Park S.J., Park D.H., Huh Y., Park C., Cheong J.H., Lee K.T., Shin C.Y., Ryu J.H. Sinapic acid attenuates kainic acid-induced hippocampal neuronal damage in mice. Neuropharmacology 2010, 59:20-30.
18. Lau A., Tymianski M. Glutamate receptors, neurotoxicity and neurodegeneration. Pflugers Arch. 2010, 460:525-542.
19. Lee S.H., Chun W., Kong P.J., Han J.A., Cho B.P., Kwon O.Y., Lee H.J., Kim S.S. Sustained activation of Akt by melatonin contributes to the protection against kainic acid-induced neuronal death in hippocampus. J. Pineal Res. 2006, 40:79-85.
20. Liang L.P., Beaudoin M.E., Fritz M.J., Fulton R., Patel M. Kainate-induced seizures, oxidative stress and neuronal loss in aging rats. Neuroscience 2007, 147:1114-1118.
21. Lin T.Y., Lu C.W., Chang C.C., Huang S.K., Wang S.J. Luteolin inhibits the release of glutamate in rat cerebrocortical nerve terminals. J. Agric. Food Chem. 2011, 59:8458-8466.
22. Lin K.C., Wang C.C., Wang S.J. Bupropion attenuates kainic acid-induced seizures and neuronal cell death in rat hippocampus. Prog. Neuropsychopharmacol. Biol. Psychiatry 2013, 45:207-214.
23. Liu Y., Tian X., Gou L., Sun L., Ling X., Yin X. Luteolin attenuates diabetes-associated cognitive decline in rats. Brain Res. Bull. 2013, 94:23-29.
24. Lopez-Lazaro M. Distribution and biological activities of the flavonoid luteolin. Mini Rev. Med. Chem. 2009, 9:31-59.
25. Masumizu T., Noda Y., Mori A., Packer L. Electron spin resonance assay of ascorbyl radical generation in mouse hippocampal slices during and after kainate-induced seizures. Brain Res. Brain Res. Protoc. 2005, 16:65-69.
26. Meldrum B.S. Glutamate as a neurotransmitter in the brain: review of physiology and pathology. J. Nutr. 2000, 130:1007S-1015S.
27. Middleton E., Kandaswami C., Theoharides T.C. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. Pharmacol. Rev. 2000, 52:673-751.
28. Morishima Y., Miyakawa T., Furuyashiki T., Tanaka Y., Mizuma H., Nakanishi S. Enhanced cocaine responsiveness and impaired motor coordination in metabotropic glutamate receptor subtype 2 knockout mice. Proc. Natl. Acad. Sci. U. S. A. 2005, 102:4170-4175.
29. Nabavi S.F., Braidy N., Gortzi O., Sobarzo-Sanchez E., Daglia M., Skalicka-Wozniak K., Nabavi S.M. Luteolin as an anti-inflammatory and neuroprotective agent: a brief review. Brain Res. Bull. 2015, 119:1-11.
30. Nazari Q.A., Kume T., Takada-Takatori Y., Izumi Y., Akaike A. Protective effect of luteolin on an oxidative-stress model induced by microinjection of sodium nitroprusside in mice. J. Pharmacol. Sci. 2013, 122:109-117.
31. Patil S.P., Jain P.D., Sancheti J.S., Ghumatkar P.J., Tambe R., Sathaye S. Neuroprotective and neurotrophic effects of apigenin and luteolin in MPTP induced Parkinsonism in mice. Neuropharmacology 2014, 86:192-202.
32. Piermartiri T.C., Vandresen-Filho S., de Araujo Herculano B., Martins W.C., Dalagnolo D., Stroeh E., Carqueja C.L., Boeck C.R., Tasca C.I. Atorvastatin prevents hippocampal cell death due to quinolinic acid-induced seizures in mice by increasing Akt phosphorylation and glutamate uptake. Neurotox. Res. 2009, 16:106-115.
33. Qiao H., Zhang X., Zhu C., Dong L., Wang L., Zhang X., Xing Y., Wang C., Ji Y., Cao X. Luteolin downregulates TLR4, TLR5, NF-κB and p-p38MAPK expression, upregulates the p-ERK expression, and protects rat brains against focal ischemia. Brain Res. 2012, 1448:71-81.
34. Racine R.J. Modification of seizure activity by electric stimulation: II. Motor seizure. Clin. Neurophysiol. 1972, 32:281-294.
35. Romagnolo D.F., Selmin Q.I. Flavonoids and cancer prevention: a review of the evidence. J. Nutr. Gerontol. Geriatr. 2012, 31:206-238.
36. Sattler R., Tymianski M. Molecular mechanisms of glutamate receptor-mediated excitotoxic neuronal cell death. Mol. Neurobiol. 2001, 24:107-129.
37. Schmued L.C., Hopkins K.J. Fluoro-Jade B: a high affinity fluorescent marker for the localization of neuronal degeneration. Brain Res. 2000, 874:123-130.
38. Shaikh M.F., Tan K.N., Borges K. Anticonvulsant screening of luteolin in four mouse seizure models. Neurosci. Lett. 2013, 550:195-199.
39. 3H]glutamate in hippocampal nerve endings. Neuropharmacology 2007, 52:598-605.
40. Smialowska M., Golembiowska K., Kajta M., Zieba B., Dziubina A., Domin H. Selective mGluR1 antagonist EMQMICM inhibits the kainate-induced excitotoxicity in primary neuronal cultures and in the rat hippocampus. Neurotox. Res. 2012, 21:379-392.
41. Solanki I., Parihar P., Mansuri M.L., Parihar M.S. Flavonoid-based therapies in the early management of neurodegenerative diseases. Adv. Nutr. 2015, 6:64-72.
42. Spencer J.P. Flavonoids: modulators of brain function. Br. J. Nutr. 2012, 99:ES60-ES77.
43. Spigolon G., Veronesi C., Bonny C., Vercelli A. c-Jun n-terminal kinase signaling pathway in excitotoxic cell death following kainic acid-induced status epilepticus. Eur. J. Neurosci. 2010, 31:1261-1272.
44. Wade J.V., Samson F.E., Nelson S.R., Pazdernik T.L. Changes in extracellular amino acids during soman- and kainic acid-induced seizures. J. Neurochem. 1987, 49:645-650.
45. Wang S.J., Sihra T.S., Gean P.W. Lamotrigine inhibition of glutamate release from isolated cerebrocortical nerve terminals (synaptosomes) by suppression of voltage-activated calcium channel activity. Neuroreport 2001, 12:2255-2258.
46. Wang Q., Yu S., Simonyi A., Sun G.Y., Sun A.Y. Kainic acid-mediated excitotoxicity as a model for neurodegeneration. Mol. Neurobiol. 2005, 31:3-16.
47. Xu B., Li X.X., He G.R., Hu J.J., Mu X., Tian S., Du G.H. Luteolin promotes long-term potentiation and improves cognitive functions in chronic cerebral hypoperfused rats. Eur. J. Pharmacol. 2010, 627:99-105.
48. Xu J., Wang H., Ding K., Zhang L., Wang C., Li T., Wei W., Lu X. Luteolin provides neuroprotection in models of traumatic brain injury via the Nrf2-ARE pathway. Free Radic. Biol. Med. 2014, 71:186-195.
49. Yang L.L., Zhou Y., Tian W.D., Li H.J., Kang-Chu-Li Miao X., An G.Z., Wang X.W., Guo G.Z., Ding G.R. Electromagnetic pulse activated brain microglia via the p38 MAPK pathway. Neurotoxicology 2016, 52:144-149.
50. Zahr N.M., Crawford E.L., Hsu O., Vinco S., Mayer D., Rohlfing T., Sullivan E.V., Pfefferbaum A. In vivo glutamate decline associated with kainic acid-induced status epilepticus. Brain Res. 2009, 1300:65-78.
51. Zhang X.M., Jin T., Quezada H.C., Mix E., Winblad B., Zhu J. Kainic acid-induced microglial activation is attenuated in aged interleukin-18 deficient mice. J. Neuroinflamm. 2010, 7:26.
52. Zhang Y.C., Gan F.F., Shelar S.B., Ng K.Y., Antioxidant Chew E.H. Nrf2 inducing activities of luteolin, a flavonoid constituent in lxeris sonchifolia Hance, provide neuroprotective effects against ischemia-induced cellular injury. Food Chem. Toxicol. 2013, 59:272-280.
53. Zheng X.Y., Zhang H.L., Luo Q., Zhu J. Kainic acid-induced neurodegeneration model: potentials and limitations. J. Biomed. Biotechnol. 2011, 2011:457079.